about
Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.2D and 3D similarity landscape analysis identifies PARP as a novel off-target for the drug Vatalanib.WITHDRAWN--a resource for withdrawn and discontinued drugsChemical Proteomics Reveals Ferrochelatase as a Common Off-target of Kinase Inhibitors.CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.SuperDRUG2: a one stop resource for approved/marketed drugs.The target landscape of clinical kinase drugs.Exploring Activity Profiles of PAINS and Their Structural Context in Target–Ligand ComplexesMolecular basis for the sensitivity of TRP channels to polyunsaturated fatty acids
P50
Q28547607-34CDDA6E-0D1E-4E1C-BBAB-3C7B905977D1Q35786901-A5B8D03C-F5B4-4774-8A26-D0163B0AE068Q36434790-09914f7d-4f44-b1d5-ab30-5cfdb4a6b6dfQ38795227-12BF594F-9392-4DCD-A65A-F387BB0990FBQ38817942-569c60fb-4450-68e5-eadb-7517d7f98924Q47142191-c3a6b59d-4fa8-98bc-121b-2622fe15376cQ47345032-7FFA98E3-C35E-4F69-A269-C5278C48AB38Q56919637-33C1A47C-FABF-4A7A-806B-154DCD2FF739Q56919661-8EDC84C9-91C3-46BF-A81A-2F396EEF9802
P50
description
onderzoeker
@nl
scientist
@en
name
Bjoern Gohlke
@ast
Bjoern Gohlke
@en
Bjoern Gohlke
@es
Bjoern Gohlke
@nl
Bjoern Gohlke
@sl
type
label
Bjoern Gohlke
@ast
Bjoern Gohlke
@en
Bjoern Gohlke
@es
Bjoern Gohlke
@nl
Bjoern Gohlke
@sl
altLabel
Bjoern Oliver Gohlke
@en
Bjoern-Oliver Gohlke
@en
Björn O Gohlke
@en
Björn-O. Gohlke
@en
Björn-Oliver Gohlke
@en
prefLabel
Bjoern Gohlke
@ast
Bjoern Gohlke
@en
Bjoern Gohlke
@es
Bjoern Gohlke
@nl
Bjoern Gohlke
@sl
P106
P108
P2038
Bjoern_Gohlke
P2456
P31
P496
0000-0003-3094-1031
P6634
bjoernolivergohlke